Shares of National Research Corp. (NASDAQ:NRCIB) have been given a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.
Brokers have set a 1 year consensus target price of $45.00 for the company and are predicting that the company will post $0.19 EPS for the current quarter, according to Zacks. Zacks has also given National Research Corp. an industry rank of 101 out of 265 based on the ratings given to its competitors.
Separately, Zacks Investment Research lowered National Research Corp. from a “buy” rating to a “hold” rating in a research report on Wednesday.
In other news, CEO Michael D. Hays sold 3,533 shares of the company’s stock in a transaction that occurred on Monday, September 19th. The stock was sold at an average price of $16.19, for a total transaction of $57,199.27. Following the transaction, the chief executive officer now directly owns 6,467,744 shares of the company’s stock, valued at $104,712,775.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 39.09% of the company’s stock.
An institutional investor recently bought a new position in National Research Corp. stock. Willis Investment Counsel bought a new position in National Research Corp. (NASDAQ:NRCIB) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 13,329 shares of the company’s stock, valued at approximately $442,000. Willis Investment Counsel owned 0.06% of National Research Corp. as of its most recent SEC filing. Institutional investors own 2.90% of the company’s stock.
National Research Corp. (NASDAQ:NRCIB) opened at 35.2493 on Tuesday. National Research Corp. has a 52-week low of $31.88 and a 52-week high of $44.60. The company has a market capitalization of $853.77 million, a PE ratio of 43.3038 and a beta of 0.28. The firm’s 50-day moving average is $35.02 and its 200-day moving average is $35.28.
National Research Corp. (NASDAQ:NRCIB) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported $0.18 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.18. National Research Corp. had a return on equity of 33.74% and a net margin of 18.75%. On average, equities research analysts forecast that National Research Corp. will post $0.82 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Friday, October 14th. Stockholders of record on Friday, September 30th were given a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 5.45%. The ex-dividend date of this dividend was Wednesday, September 28th. National Research Corp.’s payout ratio is 408.52%.
National Research Corp. is a business services company in the Health Care Services industry.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Research Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corp. and related companies with MarketBeat.com's FREE daily email newsletter.